Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (501-510 of 560) with videos related to

Pageof 56
Sort By:
The Oncologist|March 10, 2026
Long-Term Health-Related Quality of Life and Lifestyle Behavior of Patients with Acute Myeloid LeukemiaFabio Efficace, Laura Cannella, Xavier Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2015
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199Bryan P Schneider, Lang Li, Milan Radovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trialBryan P Schneider, Robert J Gray, Milan Radovich, et al.
NPJ Breast Cancer|September 2, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapyGeorge S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, et al.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast CancerKeith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
JAMA Network Open|May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORxLynne I Wagner, Robert J Gray, Joseph A Sparano, et al.
Blood|September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patientsStefan K Barta, Xiaonan Xue, Dan Wang, et al.
Pageof 56

Showing results (501-510 of 560) with videos related to

Sort By:
Pageof 56
The Oncologist|March 10, 2026
Long-Term Health-Related Quality of Life and Lifestyle Behavior of Patients with Acute Myeloid LeukemiaFabio Efficace, Laura Cannella, Xavier Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2015
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199Bryan P Schneider, Lang Li, Milan Radovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trialBryan P Schneider, Robert J Gray, Milan Radovich, et al.
NPJ Breast Cancer|September 2, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapyGeorge S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, et al.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast CancerKeith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
JAMA Network Open|May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORxLynne I Wagner, Robert J Gray, Joseph A Sparano, et al.
Blood|September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patientsStefan K Barta, Xiaonan Xue, Dan Wang, et al.
Pageof 56